NCMP-09. POSTMORTEM STUDY OF ORGAN SPECIFIC TOXICITY IN GLIOBLASTOMA PATIENTS TREATED WITH A COMBINATION OF TEMOZOLOMIDE, BEVACIZUMAB AND IRINOTECAN

Combined chemotherapy with temozolomide (TMZ), bevacizumab (BEV) and irinotecan (IRI) [TBI] has been used in patients with recurrent or progressive high-grade gliomas. Patients tolerated the regimen well with increased frequency of reversible clinical myelosuppression (CM), hypertension and proteinu...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Zhu, Jay-Jiguang, Lu, Guangrong, Rao, Mayank, Zhu, Ping, Linendoll, Nadine, Tian, Xuejun, Pilichowska, Monika, Wu, Julian, Glass, William, Bhattacharjee, Meenakshi, Ballester, Leomar Y, Chen, Lei, Zhang, Rongzhen, Pillai, Anil, Buja, L Maximilian, Hunter, Robert
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2020
Gaiak:
Neurological Complications of Cancer
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651003/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.521
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak